{"id":"https://openalex.org/W2154336328","doi":"https://doi.org/10.1128/aac.50.1.286-293.2006","title":"Multiple-Dose Pharmacokinetics and Safety of the New Antifungal Triazole BAL4815 after Intravenous Infusion and Oral Administration of Its Prodrug, BAL8557, in Healthy Volunteers","display_name":"Multiple-Dose Pharmacokinetics and Safety of the New Antifungal Triazole BAL4815 after Intravenous Infusion and Oral Administration of Its Prodrug, BAL8557, in Healthy Volunteers","alternate_titles":[],"publication_year":2005,"publication_date":"2005-12-23","ids":{"openalex":"https://openalex.org/W2154336328","doi":"https://doi.org/10.1128/aac.50.1.286-293.2006","mag":"2154336328","pmid":"https://pubmed.ncbi.nlm.nih.gov/16377699","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/1346776"},"language":"en","primary_location":{"id":"doi:10.1128/aac.50.1.286-293.2006","doi":"https://doi.org/10.1128/aac.50.1.286-293.2006","is_oa":false,"landing_page_url":"https://doi.org/10.1128/aac.50.1.286-293.2006","pdf_url":null,"source":{"id":"https://openalex.org/S47215897","display_name":"Antimicrobial Agents and Chemotherapy","issn_l":"0066-4804","issn":["0066-4804","1070-6283","1098-6596"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320263","host_organization_name":"American Society for Microbiology","host_organization_lineage":["https://openalex.org/P4310320263"],"host_organization_lineage_names":["American Society for Microbiology"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antimicrobial Agents and Chemotherapy","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2154336328"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/1346776","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5110213572","display_name":"Anne H. Schmitt\u2010Hoffmann","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210141406","display_name":"Basilea Pharmaceutica (Switzerland)","ror":"https://ror.org/04n4q2213","country_code":"CH","type":"company","lineage":["https://openalex.org/I4210141406"]}],"countries":["CH"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Anne Schmitt-Hoffmann","raw_affiliation_strings":["Basilea Pharmaceutica, Ltd., 4002 Basel, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Basilea Pharmaceutica, Ltd., 4002 Basel, Switzerland","institution_ids":["https://openalex.org/I4210141406"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108530204","display_name":"Brigitte Roos","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210141406","display_name":"Basilea Pharmaceutica (Switzerland)","ror":"https://ror.org/04n4q2213","country_code":"CH","type":"company","lineage":["https://openalex.org/I4210141406"]}],"countries":["CH"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Brigitte Roos","raw_affiliation_strings":["Basilea Pharmaceutica, Ltd., 4002 Basel, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Basilea Pharmaceutica, Ltd., 4002 Basel, Switzerland","institution_ids":["https://openalex.org/I4210141406"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074629106","display_name":"J. Maares","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210141406","display_name":"Basilea Pharmaceutica (Switzerland)","ror":"https://ror.org/04n4q2213","country_code":"CH","type":"company","lineage":["https://openalex.org/I4210141406"]}],"countries":["CH"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Ju\u0308rgen Maares","raw_affiliation_strings":["Basilea Pharmaceutica, Ltd., 4002 Basel, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Basilea Pharmaceutica, Ltd., 4002 Basel, Switzerland","institution_ids":["https://openalex.org/I4210141406"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086889166","display_name":"Markus Heep","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210141406","display_name":"Basilea Pharmaceutica (Switzerland)","ror":"https://ror.org/04n4q2213","country_code":"CH","type":"company","lineage":["https://openalex.org/I4210141406"]}],"countries":["CH"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Markus Heep","raw_affiliation_strings":["Basilea Pharmaceutica, Ltd., 4002 Basel, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Basilea Pharmaceutica, Ltd., 4002 Basel, Switzerland","institution_ids":["https://openalex.org/I4210141406"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057820270","display_name":"Jochen Spickermann","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210141406","display_name":"Basilea Pharmaceutica (Switzerland)","ror":"https://ror.org/04n4q2213","country_code":"CH","type":"company","lineage":["https://openalex.org/I4210141406"]}],"countries":["CH"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Jochen Spickerman","raw_affiliation_strings":["Basilea Pharmaceutica, Ltd., 4002 Basel, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Basilea Pharmaceutica, Ltd., 4002 Basel, Switzerland","institution_ids":["https://openalex.org/I4210141406"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025796935","display_name":"Erhard Weidekamm","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210141406","display_name":"Basilea Pharmaceutica (Switzerland)","ror":"https://ror.org/04n4q2213","country_code":"CH","type":"company","lineage":["https://openalex.org/I4210141406"]}],"countries":["CH"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Erhard Weidekamm","raw_affiliation_strings":["Basilea Pharmaceutica, Ltd., 4002 Basel, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Basilea Pharmaceutica, Ltd., 4002 Basel, Switzerland","institution_ids":["https://openalex.org/I4210141406"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Tom Brown","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210141406","display_name":"Basilea Pharmaceutica (Switzerland)","ror":"https://ror.org/04n4q2213","country_code":"CH","type":"company","lineage":["https://openalex.org/I4210141406"]}],"countries":["CH"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Tom Brown","raw_affiliation_strings":["Basilea Pharmaceutica, Ltd., 4002 Basel, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Basilea Pharmaceutica, Ltd., 4002 Basel, Switzerland","institution_ids":["https://openalex.org/I4210141406"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5023735394","display_name":"Michael Roehrle","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Michael Roehrle","raw_affiliation_strings":["AAI, 89231 Neu-Ulm, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AAI, 89231 Neu-Ulm, Germany","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5110213572"],"corresponding_institution_ids":["https://openalex.org/I4210141406"],"apc_list":null,"apc_paid":null,"fwci":2.1528,"has_fulltext":false,"cited_by_count":150,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.85646985,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":92,"max":100},"biblio":{"volume":"50","issue":"1","first_page":"286","last_page":"293"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10150","display_name":"Antifungal resistance and susceptibility","score":0.9911999702453613,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10150","display_name":"Antifungal resistance and susceptibility","score":0.9911999702453613,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11036","display_name":"Antibiotics Pharmacokinetics and Efficacy","score":0.004000000189989805,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12547","display_name":"Pharmaceutical studies and practices","score":0.0010999999940395355,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/prodrugs","display_name":"prodrugs","score":0.9440000057220459},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.9340000152587891},{"id":"https://openalex.org/keywords/repeated-dosing","display_name":"repeated dosing","score":0.7919999957084656},{"id":"https://openalex.org/keywords/oral-bioavailability","display_name":"oral bioavailability","score":0.8399999737739563},{"id":"https://openalex.org/keywords/intravenous-infusion","display_name":"intravenous infusion","score":0.949999988079071},{"id":"https://openalex.org/keywords/drug-accumulation","display_name":"drug accumulation","score":0.5329999923706055},{"id":"https://openalex.org/keywords/elimination-half-life","display_name":"elimination half-life","score":0.75},{"id":"https://openalex.org/keywords/volume-of-distribution","display_name":"volume of distribution","score":0.8579999804496765},{"id":"https://openalex.org/keywords/systemic-clearance","display_name":"systemic clearance","score":0.8799999952316284},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.6499999761581421},{"id":"https://openalex.org/keywords/esophageal-candidiasis","display_name":"esophageal candidiasis","score":0.9380000233650208},{"id":"https://openalex.org/keywords/systemic-fungal-infection","display_name":"systemic fungal infection","score":0.9710000157356262}],"concepts":[{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.8045207262039185},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7186805605888367},{"id":"https://openalex.org/C108215921","wikidata":"https://www.wikidata.org/wiki/Q603741","display_name":"Prodrug","level":2,"score":0.6902137398719788},{"id":"https://openalex.org/C139254425","wikidata":"https://www.wikidata.org/wiki/Q1332167","display_name":"Volume of distribution","level":3,"score":0.649516761302948},{"id":"https://openalex.org/C2777056448","wikidata":"https://www.wikidata.org/wiki/Q285166","display_name":"Oral administration","level":2,"score":0.6206296682357788},{"id":"https://openalex.org/C2777288759","wikidata":"https://www.wikidata.org/wiki/Q4164182","display_name":"Dosing","level":2,"score":0.6164820194244385},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.5465497970581055},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5267614126205444},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.4900749921798706},{"id":"https://openalex.org/C111113717","wikidata":"https://www.wikidata.org/wiki/Q725307","display_name":"Pharmacodynamics","level":3,"score":0.4588949680328369},{"id":"https://openalex.org/C176674119","wikidata":"https://www.wikidata.org/wiki/Q11582","display_name":"Liter","level":2,"score":0.45664331316947937},{"id":"https://openalex.org/C35294091","wikidata":"https://www.wikidata.org/wiki/Q6663385","display_name":"Loading dose","level":2,"score":0.4149877429008484},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.3860064446926117},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3003787100315094},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000284","descriptor_name":"Administration, Oral","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000935","descriptor_name":"Antifungal Agents","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D000935","descriptor_name":"Antifungal Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D000935","descriptor_name":"Antifungal Agents","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D001682","descriptor_name":"Biological Availability","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005658","descriptor_name":"Fungi","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D006207","descriptor_name":"Half-Life","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007262","descriptor_name":"Infusions, Intravenous","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009570","descriptor_name":"Nitriles","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D009570","descriptor_name":"Nitriles","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D009570","descriptor_name":"Nitriles","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D011355","descriptor_name":"Prodrugs","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D011725","descriptor_name":"Pyridines","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D011725","descriptor_name":"Pyridines","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D011725","descriptor_name":"Pyridines","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D012449","descriptor_name":"Safety","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014230","descriptor_name":"Triazoles","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D014230","descriptor_name":"Triazoles","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D014230","descriptor_name":"Triazoles","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D015331","descriptor_name":"Cohort Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D064368","descriptor_name":"Healthy Volunteers","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1128/aac.50.1.286-293.2006","doi":"https://doi.org/10.1128/aac.50.1.286-293.2006","is_oa":false,"landing_page_url":"https://doi.org/10.1128/aac.50.1.286-293.2006","pdf_url":null,"source":{"id":"https://openalex.org/S47215897","display_name":"Antimicrobial Agents and Chemotherapy","issn_l":"0066-4804","issn":["0066-4804","1070-6283","1098-6596"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320263","host_organization_name":"American Society for Microbiology","host_organization_lineage":["https://openalex.org/P4310320263"],"host_organization_lineage_names":["American Society for Microbiology"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antimicrobial Agents and Chemotherapy","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:489440","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/1346776","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:1346776","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC1346776/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antimicrob Agents Chemother","raw_type":"Text"},{"id":"pmid:16377699","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/16377699","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antimicrobial agents and chemotherapy","raw_type":"Journal Article"}],"best_oa_location":{"id":"pmh:oai:europepmc.org:489440","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/1346776","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.98580002784729}],"study_designs":[{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":18,"referenced_works":["https://openalex.org/W88967424","https://openalex.org/W1971237695","https://openalex.org/W1978263354","https://openalex.org/W1997756754","https://openalex.org/W2029293133","https://openalex.org/W2069676455","https://openalex.org/W2078752490","https://openalex.org/W2083968901","https://openalex.org/W2087539652","https://openalex.org/W2094792978","https://openalex.org/W2096521991","https://openalex.org/W2107471693","https://openalex.org/W2140702464","https://openalex.org/W2156251261","https://openalex.org/W2338539235","https://openalex.org/W2340093072","https://openalex.org/W2399195461","https://openalex.org/W2618242172"],"related_works":["https://openalex.org/W2096521991","https://openalex.org/W2083087695","https://openalex.org/W141423785","https://openalex.org/W2134631351","https://openalex.org/W4247060083","https://openalex.org/W2101101109","https://openalex.org/W2114998899","https://openalex.org/W4394750184","https://openalex.org/W2099424092","https://openalex.org/W1563224671"],"abstract_inverted_index":{"BAL8557":[0,37,261],"is":[1,153],"the":[2,76,123,133,157,165,176,198,202,230,291],"water-soluble":[3],"prodrug":[4],"of":[5,32,36,48,59,62,111,128,144,161,178,207,222,255,260,293],"BAL4815,":[6],"a":[7,139,269],"new":[8],"broad-spectrum":[9],"antifungal.":[10],"Healthy":[11],"male":[12],"subjects":[13,68,74],"were":[14,38,92,262],"randomly":[15],"assigned":[16],"to":[17,21,40,105,132,141,170,184,186,194,265],"four":[18],"treatment":[19,292],"cohorts":[20],"receive":[22],"multiple":[23,27],"oral":[24,213,239,245,253],"doses":[25,35,47,58,280],"or":[26,51,94,225,257],"1-h":[28],"constant-rate":[29],"intravenous":[30,215,241],"infusions":[31],"BAL8557.":[33],"Loading":[34],"equivalent":[39],"100":[41,60],"mg":[42,53],"(followed":[43,54],"by":[44,55,229,282],"once-daily":[45,56,150],"maintenance":[46,57],"50":[49],"mg)":[50,61],"200":[52],"BAL4815.":[63,251],"In":[64],"each":[65],"cohort,":[66],"six":[67],"received":[69,75],"active":[70,145],"drug":[71,114,146],"and":[72,84,120,182,209,214,240],"two":[73],"placebo.":[77],"Study":[78],"duration":[79],"was":[80,102,180,219],"21":[81],"days":[82,86],"(oral)":[83],"14":[85],"(intravenous).":[87],"All":[88],"adverse":[89],"events":[90],"reported":[91],"mild":[93],"moderate,":[95],"except":[96],"one":[97],"severe":[98],"rhinitis":[99],"event":[100],"which":[101,152],"not":[103],"related":[104],"trial":[106],"medication.":[107],"After":[108],"both":[109],"routes":[110],"administration,":[112,242],"maximum":[113],"concentration":[115],"observed":[116],"in":[117,147,154,201,268,290],"plasma":[118,148],"(C(max))":[119],"area":[121],"under":[122],"concentration-time":[124],"curve":[125],"(AUC)":[126],"values":[127,137,206,237],"BAL4815":[129,162],"increased":[130],"proportionally":[131],"administered":[134],"dose.":[135],"AUC":[136,236],"reflected":[138],"fourfold":[140],"fivefold":[142],"accumulation":[143],"during":[149],"dosing,":[151],"line":[155],"with":[156,274,276],"long":[158],"elimination":[159],"half-life":[160],"determined":[163],"after":[164,212,238],"last":[166],"administration":[167],"(mean,":[168],"84.5":[169],"117":[171],"h).":[172],"At":[173,197],"steady":[174],"state,":[175],"volume":[177],"distribution":[179],"large":[181],"amounted":[183],"308":[185],"542":[187],"liters.":[188],"Systemic":[189],"clearance":[190],"reached":[191],"only":[192],"2.4":[193],"4.1":[195],"liter/h.":[196],"levels":[199],"obtained":[200],"present":[203],"study,":[204],"C(max)":[205],"2.56":[208],"2.55":[210],"microg/ml":[211],"administrations,":[216],"respectively,":[217],"there":[218],"no":[220],"indication":[221],"CYP3A4":[223],"induction":[224],"inhibition":[226],"(as":[227],"revealed":[228],"urinary":[231],"6-beta-hydroxycortisol/cortisol":[232],"test).":[233],"Based":[234],"on":[235],"an":[243],"excellent":[244],"bioavailability":[246],"can":[247],"be":[248,266,287],"predicted":[249],"for":[250],"Once-daily":[252],"dosing":[254],"50-":[256],"100-mg":[258],"equivalents":[259],"recently":[263],"demonstrated":[264],"efficacious":[267],"phase":[270],"2":[271],"study":[272],"conducted":[273],"patients":[275],"esophageal":[277],"candidiasis.":[278],"These":[279],"(preceded":[281],"adequate":[283],"loading":[284],"dose[s])":[285],"will":[286],"further":[288],"explored":[289],"systemic":[294],"mycoses.":[295]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2154336328","counts_by_year":[{"year":2026,"cited_by_count":6},{"year":2025,"cited_by_count":4},{"year":2024,"cited_by_count":5},{"year":2023,"cited_by_count":11},{"year":2022,"cited_by_count":7},{"year":2021,"cited_by_count":5},{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":12},{"year":2018,"cited_by_count":11},{"year":2017,"cited_by_count":15},{"year":2016,"cited_by_count":17},{"year":2015,"cited_by_count":15},{"year":2014,"cited_by_count":5},{"year":2013,"cited_by_count":6},{"year":2012,"cited_by_count":2}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
